
A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor α
Keywords: Rheumatoid arthritis; Dual targeting fusion protein; Interleukin 17A; Tumor necrosis factor α; Treg/Th17 cell; RANKL/OPG;